Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03489525
Title MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma (MEDI2228)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.